Projekt

Research project on life course influences, trends and trajectories in health and functioning, and welfare state changes and inequality impacts of recent social reforms.

During the last decades refugee immigration has changed the societal weave of the Nordic welfare states. There are many indications that the socioeconomic as well as the health situation of these new Nordic citizens are less favourable compared with the majority populations.

Nordic countries share similar working life structures and basis for working hour regulations. The overall aim of the project is to develop evidence-based models and solutions related to working hours to support health, well-being and work participation among employees in the Nordic countries.

The Committee of Nordic ART and Safety (CoNARTaS) was established five year ago and have the responsibility for the Nordic ART and Safety database including all children born after assisted reproductive technology (ART) in Finland, Norway, Sweden and Denmark since 1982.

Crohn's disease is a chronic inflammatory bowel disease. The biological drug Remicade is used in patients with Crohn's disease when normal treatment is inadequate. About one in three of the patients starting treatment with Remicade have sustained good effect over several years. However, serious side effects such as; infections, allergic reactions and concerns about long-term safety, with suspected increased risk of developing cancer, necessitate exploring strategies for when and in which patients to stop (discontinue) treatment again.

The NORD-STAR clinical trial will provide extremely valuable information on the treatment of early rheumatoid arthritis. The study aims to find out, which is the most effective treatment strategy in early rheumatoid arthritis. As the first trial ever it will compare four different treatment modalities head-to-head.